Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma

NCT05472766 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Study terminated due to logistical challenges in conducting the trial.

Conditions

Subdural Hematoma
Atrial Fibrillation

Interventions

DRUG: Direct Acting Oral Anticoagulant starting at Day 30
DRUG: Direct Acting Oral Anticoagulant starting at Day 90

Sponsor

Sunnybrook Health Sciences Centre